PME
$14.7BCF+
Pro Medicus
Medical imaging
Visage Imaging radiology platform — AI-driven workflows used by 50+ major health systems globally
Cash data from Dec 2025 4CFigures from ASX filings · not financial advice
[ VITALS ]
Cash on Hand
$0.0M
Dec 2025 4C
Runway
CF+Cash Flow Positive
Based on Dec 2025 4C
Market Cap
$14.7B
Burn Rate
—
Dec 2025 4C
Shares Outstanding
104M
Pipeline Assets
2
Latest Insight(1)
13 Apr 2026substantial_holderBecoming a substantial holder
New holder·State Street Corporation and subsidiaries·5.01%
3M Price
PME.ASX$140.580-20.6% 3M
Low $107.852High $189.646
Pipeline Assets (2)
Visage 7Diagnostic imaging platform (radiology PACS)
ApprovedVisage 7 Open ArchiveVendor-neutral image archive
ApprovedDiscovery
Preclinical
Ph 1
Ph 1/2
Ph 2
Ph 2/3
Ph 3
NDA
Approved
Visage 7
Diagnostic imaging platform (radiology PACS)
Capital Raises & Buybacks
4 buybacks
Current shares outstanding: 104M
Buyback
Buyback Detail
2026-04-01on-market
2026-04-01on-market
$11.6M
Director Transactions
1 transactionLast 90dNet Buy
Buys1+1 vs prior
Sells0
Buy Value$994k
$993,8122026-02-26
Substantial Holders (5%+ threshold)
1 noticeINITIALState Street Corporation and subsidiaries
5.01%2026-04-13
Director Options & Rights
Director
Outstanding
Ex. Price
Expiry
No option data entered yet
Catalysts (3)
FY2026 full-year results
UpcomingConfirmedarrow_upwardHigh19 Aug 2026
First digital pathology client deployment
UpcomingExpectedarrow_upwardHigh30 Sept 2026
University of Maryland Medical System go-live
UpcomingConfirmedremoveMed31 Mar 2027
| Event | Type | Confidence | Impact | Date | Status |
|---|
Delivery Consistency Index
Historical delivery and spending consistency — data is limited for recently added companies.
Track record will build as data accumulates — we need completed catalysts with original guidance dates, or at least two quarterly 4Cs, before scoring kicks in.